Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies.
about
Foundation clinical trialsEffective incorporation of biomarkers into phase II trialsDevelopment of Targeted Therapies in ErbB2-Positive Breast CancerEffectiveness of adjuvant trastuzumab in daily clinical practiceEfficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer.Trastuzumab-Associated Flagellate Erythema: Report in a Woman with Metastatic Breast Cancer and Review of Antineoplastic Therapy-Induced Flagellate Dermatoses.Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy.Validation of analytic methods for biomarkers used in drug development
P2860
Q33555580-E629A38C-A7C0-426D-B640-D69BE9AE7136Q33870594-A1C95BB0-47F2-4C08-966D-B4A44421FAC4Q34095743-F570D12A-DCB4-4B38-8553-12597939B06CQ34503912-43F70ECF-9DC0-4E3B-84B3-C00589B85AC2Q35584206-0D2E616B-A7FE-4A15-BDEA-31D305867646Q35913214-EA3E6480-1F90-4E81-B901-04D52150DC1DQ36359992-7A72E87F-5C44-49B0-A136-DC72ADD726BAQ37163797-CA5050B6-E62A-4DFB-9A32-93469D0E5F30Q37284255-E41F10EA-A6B4-4A96-9702-EB153865F03A
P2860
Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@ast
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@en
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@nl
type
label
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@ast
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@en
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@nl
prefLabel
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@ast
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@en
Efficacy and safety of Hercept ...... from pivotal clinical studies.
@nl
P1433
P1476
Efficacy and safety of Hercept ...... from pivotal clinical studies
@en
P2093
P356
10.1097/00001813-200112004-00002
P478
12 Suppl 4
P577
2001-12-01T00:00:00Z